Skip to main content

Argenica partner with Curtin to study stroke drugs' impact on concussion

Just in

Bookmark

Save articles for future reference.
Share to

Curtin University research has found Argenica's flagship stroke drug, which protects brain tissue from dying immediately after a stroke, can also significantly reduce the impacts of concussion.

X

To read our articles you will need to either login or subscribe.